What in the hell is Major League Baseball doing with Biogenesis?

50 Comments

It was up late last night and was sort of overwhelmed by the Dodgers-Padres brawl, but in case you missed it, go read Matthew’s post about the latest in the Biogenesis business. The upshot:  Major League Baseball is reportedly paying an ex-Biogenesis employee for documents relating to the case.

Feature how this works: your employer goes to one of you health care providers, buys your medical records from them, reads them, and then uses that information to discipline you at work.  You cool with that? If you’re not, please explain to me how what MLB is reportedly doing here is in any way defensible.

Also: if MLB is so convinced that the lawsuit they filed is righteous and justifiable, why are they now circumventing it to get the documents in question?

At some point it would be cool if MLB actually made some sort of statement about what they’re doing here. Because it makes absolutely no sense to me. How on earth do they expect any suspensions they dole out based on this tactic to hold up to an arbitrator’s review?

Report: Nathan Eovaldi drawing interest from at least nine teams

Nathan Eovaldi
Getty Images
5 Comments

Former Red Sox right-hander Nathan Eovaldi is up for grabs this offseason, and Nick Cafardo of the Boston Globe says that as many as nine suitors are interested in bringing the righty aboard. While the Red Sox are eager to retain Eovaldi’s services after his lights-out performance during their recent postseason run, they’ll have to contend with the Brewers, Phillies, Braves, White Sox, Padres, Blue Jays, Giants, and Angels — all of whom are reportedly positioned to offer something for the starter this winter.

It wasn’t all smooth sailing for the 28-year-old in 2018, however. After losing his 2017 season to Tommy John surgery, he underwent an additional procedure to remove loose bodies from his right elbow in March and didn’t make his first appearance until the end of May. He was flipped for lefty reliever Jalen Beeks just prior to the trade deadline and finished his season with a combined 6-7 record in 21 starts, a 3.81 ERA, 1.6 BB/9, and 8.2 SO/9 through 111 innings.

Despite his numerous health issues over the last few years, Eovaldi raised his stock in October after becoming a major contributor during the Red Sox’ championship run. He contributed two quality starts in the ALDS and ALCS and returned in Games 1-3 of the World Series with three lights-out performances in relief — including a six-inning effort in the 18-inning marathon that was Game 3.

A frontrunner has yet to emerge for the righty this offseason, but Cafardo points out that the nine teams listed so far might just be the tip of the iceberg. Still, he won’t be the most sought-after starter on the market, as former Diamondbacks southpaw Patrick Corbin is expected to command an even bigger payday following his career-best 6.0-fWAR performance in 2018.